These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35299122)

  • 1. Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probe.
    Batista AS; Oliveira SDS; Pomel S; Commere PH; Mazan V; Lee M; Loiseau PM; Rossi-Bergmann B; Prina E; Duval R
    Biomed Pharmacother; 2022 May; 149():112784. PubMed ID: 35299122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Novel Chalcone-Thiosemicarbazones Derivatives as Potential Anti-
    Mendes EP; Goulart CM; Chaves OA; Faiões VDS; Canto-Carvalho MM; Machado GC; Torres-Santos EC; Echevarria A
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31652866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.
    de Oliveira NS; de Souza LG; de Almeida VM; Barreto ARR; Carvalho-Gondim F; Schaeffer E; Santos-Filho OA; Rossi-Bergmann B; da Silva AJM
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300440. PubMed ID: 38048546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2',4'-dihydroxychalcone could be explored to develop new inhibitors against the glycerol-3-phosphate dehydrogenase from Leishmania species.
    Passalacqua TG; Torres FA; Nogueira CT; de Almeida L; Del Cistia ML; dos Santos MB; Dutra LA; Bolzani VS; Regasini LO; Graminha MA; Marchetto R; Zottis A
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3564-8. PubMed ID: 26169126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Targets for Chalcones in Antileishmanial Drug Discovery.
    de Santiago-Silva KM; da Silva Gomes GF; Perez CC; da Silva Lima CH; de Lima Ferreira Bispo M
    Mini Rev Med Chem; 2023; 23(14):1414-1434. PubMed ID: 36705240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.
    Zhai L; Chen M; Blom J; Theander TG; Christensen SB; Kharazmi A
    J Antimicrob Chemother; 1999 Jun; 43(6):793-803. PubMed ID: 10404318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraspecific live imaging of the dynamics of zebrafish neutrophil granules by a histopermeable fluorogenic benzochalcone probe.
    Colucci-Guyon E; Batista AS; Oliveira SDS; Blaud M; Bellettini IC; Marteyn BS; Leblanc K; Herbomel P; Duval R
    Chem Sci; 2019 Mar; 10(12):3654-3670. PubMed ID: 30996961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemotherapeutic potential of chalcones against leishmaniases: a review.
    Tajuddeen N; Isah MB; Suleiman MA; van Heerden FR; Ibrahim MA
    Int J Antimicrob Agents; 2018 Mar; 51(3):311-318. PubMed ID: 28668673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of chalcone derivatives as antileishmanial agents.
    de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
    Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro leishmanicidal activity of naturally occurring chalcones.
    Kayser O; Kiderlen AF
    Phytother Res; 2001 Mar; 15(2):148-52. PubMed ID: 11268116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.
    Chen M; Zhai L; Christensen SB; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2023-9. PubMed ID: 11408218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones.
    Aponte JC; Castillo D; Estevez Y; Gonzalez G; Arevalo J; Hammond GB; Sauvain M
    Bioorg Med Chem Lett; 2010 Jan; 20(1):100-3. PubMed ID: 19962891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
    Chen M; Christensen SB; Blom J; Lemmich E; Nadelmann L; Fich K; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2550-6. PubMed ID: 8109916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileishmanial activities of dihydrochalcones from piper elongatum and synthetic related compounds. Structural requirements for activity.
    Hermoso A; Jiménez IA; Mamani ZA; Bazzocchi IL; Piñero JE; Ravelo AG; Valladares B
    Bioorg Med Chem; 2003 Sep; 11(18):3975-80. PubMed ID: 12927858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of chalcone analogues with increased antileishmanial activity.
    Boeck P; Bandeira Falcão CA; Leal PC; Yunes RA; Filho VC; Torres-Santos EC; Rossi-Bergmann B
    Bioorg Med Chem; 2006 Mar; 14(5):1538-45. PubMed ID: 16386424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered sterol profile induced in Leishmania amazonensis by a natural dihydroxymethoxylated chalcone.
    Torres-Santos EC; Sampaio-Santos MI; Buckner FS; Yokoyama K; Gelb M; Urbina JA; Rossi-Bergmann B
    J Antimicrob Chemother; 2009 Mar; 63(3):469-72. PubMed ID: 19176591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of chalcone derivatives by Claisen-Schmidt condensation and
    Souza GB; Santos TAC; Silva APS; Barreiros ALBS; Nardelli VB; Siqueira IB; Dolabella SS; Costa EV; Alves PB; Scher R; Fernandes RPM
    Nat Prod Res; 2024 Apr; 38(8):1326-1333. PubMed ID: 36331421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. trans-Chalcone modulates Leishmania amazonensis infection in vitro by Nrf2 overexpression affecting iron availability.
    Miranda-Sapla MM; Tomiotto-Pellissier F; Assolini JP; Carloto ACM; Bortoleti BTDS; Gonçalves MD; Tavares ER; Rodrigues JHDS; Simão ANC; Yamauchi LM; Nakamura CV; Verri WA; Costa IN; Conchon-Costa I; Pavanelli WR
    Eur J Pharmacol; 2019 Jun; 853():275-288. PubMed ID: 30965057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.